Rollins School of Public Health | Faculty Profile
Emory Rollins School of Public Health

Matthew  Magee

Associate Professor

Faculty, Global Health

Jointly Appointed, Epidemiology

Dr. Magee received a BA in sociology and Spanish from Grinnell College, graduating in 2001. After Grinnell, he received a Thomas J Watson Fellowship to study hepatitis C epidemiology in Italy, India, and Australia. In 2006, Matthew earned his MPH in epidemiology from the University of Illinois at Chicago and then worked for the Asian Health Coalition of Illinois for three years as Senior Program Manager. He received his PhD in 2013 from the Department of Epidemiology at Emory University, Rollins School of Public Health. Matthew also conducted a Post-Doctoral Fellowship in the Departments of Epidemiology and Global Health at Emory University. Dr. Magee is currently an Associate Professor in the Hubert Department of Global Health, Rollins School of Public Health, Emory University. Dr. Magee's research interests focus on the intersection of non-communicable diseases and infectious diseases, principally the relation between diabetes mellitus and tuberculosis.

For a complete list of publications, see: MyBibliography

Contact Information

1518 Clifton Road NE

Atlanta , GA 30322

1518-002-7BB (SPH: Global Health)


Update Profile Here

Areas of Interest

  • Global Health
  • HIV/AIDS Prevention

Affiliations & Activities

Research Health Scientist, Clinical Studies Center, Department of Veterans Affairs, Atlanta VA Medical Center


  • , , Diabetes mellitus and risk of all-cause mortality among patients with tuberculosis in the state of Georgia, 2009-2012, Annals of Epidemiology, ,
  • , , Diabetes mellitus, smoking, and time to sputum culture conversion in multidrug-resistant tuberculosis patients, PLOS ONE, ,
  • , , HIV and metabolic, body, and bone disorders: What we know from low- and middle-income countries. , JAIDS, ,
  • , , Household income and poor treatment outcome among patients with tuberculosis in Georgia: A cohort study. , BMC Public Health, ,
  • , , Significant Clinical Impact of a Rapid Molecular Diagnostic Test (Genotype MTBDRplus Assay) to detect Multidrug-Resistant Tuberculosis. , Clinical Infectious Diseases, ,